The impact of the contraceptive medication-induced change in hormonal levels on the vaginal microbiome.
Silo Pharma’s SPU-21 Treatment for Autoimmune Disease Awarded U.S. Patent – Psychedelic Alpha
ENGLEWOOD CLIFFS, NJ, June 21, 2023 (GLOBE NEWSWIRE) — Silo Pharma, Inc. (Nasdaq: SILO) (“the Company”), a developmental stage biopharmaceutical company focused on merging traditional therapeutics